Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with aids

Louis M. Weiss; Carol Harris; Marc Berger; Herbert B. Tanowitz; Murray Wittner; Murray Wittner

doi:10.1093/infdis/157.3.580

Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with aids

Louis M. Weiss, Carol Harris, Marc Berger, Herbert B. Tanowitz, Murray Wittner, Murray Wittner

Pathology

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Abstract

Pyrimethamine (PYR) is a substituted phenylpyrimidine compound that has been used as therapy for malaria and is presently the drug of choice for acute toxoplasmosis when combined with trisulfapyrimidines or sulfadiazine. Because of its restricted use, there have been limited studies.

Original language	English (US)
Pages (from-to)	580-583
Number of pages	4
Journal	Journal of Infectious Diseases
Volume	157
Issue number	3
DOIs	https://doi.org/10.1093/infdis/157.3.580
State	Published - Mar 1988

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/infdis/157.3.580

Cite this

@article{02a2532d9bea4d49af8741d418556526,

title = "Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with aids",

abstract = "Pyrimethamine (PYR) is a substituted phenylpyrimidine compound that has been used as therapy for malaria and is presently the drug of choice for acute toxoplasmosis when combined with trisulfapyrimidines or sulfadiazine. Because of its restricted use, there have been limited studies.",

author = "Weiss, {Louis M.} and Carol Harris and Marc Berger and Tanowitz, {Herbert B.} and Murray Wittner and Murray Wittner",

year = "1988",

month = mar,

doi = "10.1093/infdis/157.3.580",

language = "English (US)",

volume = "157",

pages = "580--583",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with aids

AU - Weiss, Louis M.

AU - Harris, Carol

AU - Berger, Marc

AU - Tanowitz, Herbert B.

AU - Wittner, Murray

PY - 1988/3

Y1 - 1988/3

N2 - Pyrimethamine (PYR) is a substituted phenylpyrimidine compound that has been used as therapy for malaria and is presently the drug of choice for acute toxoplasmosis when combined with trisulfapyrimidines or sulfadiazine. Because of its restricted use, there have been limited studies.

AB - Pyrimethamine (PYR) is a substituted phenylpyrimidine compound that has been used as therapy for malaria and is presently the drug of choice for acute toxoplasmosis when combined with trisulfapyrimidines or sulfadiazine. Because of its restricted use, there have been limited studies.

UR - http://www.scopus.com/inward/record.url?scp=0023818280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023818280&partnerID=8YFLogxK

U2 - 10.1093/infdis/157.3.580

DO - 10.1093/infdis/157.3.580

M3 - Article

C2 - 3343528

AN - SCOPUS:0023818280

SN - 0022-1899

VL - 157

SP - 580

EP - 583

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 3

ER -

Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with aids

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this